Suneel Chamoli

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation.

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation.

Journal: The Australian and New Zealand journal of psychiatry
Published: May 06, 2024

Electroconvulsive Therapy Credentialing for Psychiatrists-Review of Required Standards Across States and Territories in Australia.

Electroconvulsive Therapy Credentialing for Psychiatrists-Review of Required Standards Across States and Territories in Australia.

Journal: The journal of ECT
Published: August 10, 2023

Prescribing electroconvulsive therapy for depression: Not as simple as it used to be.

Prescribing electroconvulsive therapy for depression: Not as simple as it used to be.

Journal: The Australian and New Zealand journal of psychiatry
Published: June 24, 2023

Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again.

Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again.

Journal: The Australian and New Zealand journal of psychiatry
Published: December 31, 2021

N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.

N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.

Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: November 26, 2021

Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study.

Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study.

Journal: CNS spectrums
Published: June 24, 2021

The place of non-invasive brain stimulation in the RANZCP clinical practice guidelines for mood disorders.

The place of non-invasive brain stimulation in the RANZCP clinical practice guidelines for mood disorders.

Journal: The Australian and New Zealand journal of psychiatry
Published: April 02, 2021

Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.

Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.

Journal: The Australian and New Zealand journal of psychiatry
Published: December 10, 2019

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.

Journal: Psychopharmacology
Published: May 27, 2019

Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.

Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.

Journal: Journal of affective disorders
Published: June 29, 2018

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial.

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: April 12, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026